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Materials and Methods – Supplement 19 
 20 
Animals 21 
Detailed information for mouse line generation and underlying genetics of hsFLT1/rtTA 22 
mice is previously described in Vogtmann et al. 20191. For experimental set-up in this 23 
study hsFLT1/rtTA mice (6-9-month-old) were mated overnight, and the following day 24 
was counted as 0.5-day post conception (dpc). From mid-pregnancy (10.5 dpc) until 25 
the end of the second trimester (14.5. dpc) or the end of the pregnancy (18.5 dpc), 26 
dams were treated with either 2 mg/ml doxycycline (Dox) (0.2% [w/v]; Merck, 27 
Darmstadt, Germany) and 30 mg/ml sucrose (3% [w/v]; Carl Roth, Karlsruhe, 28 
Germany) in the PE and Dox Ctrl group or with sucrose only in the Ctrl group. The 29 
experimental “PE” group is defined by double-transgenic dams having both transgenic 30 
alleles (hsFLT1 and rtTA) and receiving 2 mg/ml Dox and 30 mg/ml sucrose in the 31 
drinking water, which induced the systemic hsFLT1 overexpression. The first control 32 
group named “Ctrl”, is defined by double-transgenic dams having both transgenic 33 
alleles (hsFLT1 and rtTA) like dams of the PE group but receiving only 30 mg/ml 34 
sucrose in the drinking water without doxycycline. This control group was chosen to 35 
test for effects of the two transgenic alleles without hsFLT1 overexpression. 36 
Furthermore, a second control group was performed to test for doxycycline side effects, 37 
named “Dox Ctrl”. The Dox Ctrl group is defined by single-transgenic hsFLT1 mice 38 
lacking the rtTA allele and receiving (like the PE group) 2 mg/ml doxycycline (Dox) and 39 
30 mg/ml sucrose in the drinking water, and thus not expressing hsFLT1 but revealing 40 
possible Dox effects. Sampling was done at 14.5 (Ctrl: n=6, Dox Ctrl: n=4, PE: n=6) or 41 
18.5 dpc (Ctrl: n=11, Dox Ctrl: n=3, PE: n=11). Mice were housed in a specific-42 
pathogen–free environment at the animal facility of the University Hospital Essen or 43 
Berlin, were exposed to cycles of 12 h of light/dark and were provided with food and 44 
water ad libitum. In the parental generation of double-transgenic hsFLT1/rtTA mice, 45 
systemically expressed rtTA induces hsFLT1 expression upon Dox treatment. When 46 
Dox is added, rtTA can bind to the TetO promoter of the hsFLT1 transgene, leading to 47 
hsFLT1 expression (PE); without Dox, hsFLT1 is not expressed (Ctrl). Single 48 
transgenic hsFLT1 mice (lacking the rtTA allele) treated with Dox do not express 49 
hsFLT1 and served as a control for Dox side effects (Dox Ctrl). Since Dox passes the 50 
placental barrier, double transgenic hsFLT1/rtTA fetuses/placentas (PE hom: 51 
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homozygous for hsFLT1 and rtTA or PE het: homozygous for hsFLT1 and 52 
heterozygous for rtTA) in the first filial generation of the PE group can also express 53 
hsFLT1, whereas single transgenic fetuses/placentas (PE wt: lacking the rtTA allele) 54 
cannot. According to this, different variation of hsFLT1 expression was achieved in the 55 
PE group according to the fetal rtTA-genotype. Figure 1 A-B illustrates the distribution 56 
of hsFLT1 expression in PE wt (exclusive maternal) compared to PE het or hom group 57 
(maternal and feto-placental). 58 
 59 
In vivo blood pressure measurements by telemetry 60 
A set of mice (Ctrl n=6, PE n=6) were treated with Carprofen (5 mg/kg s.c.) prior 61 
procedure. After anesthesia by a mixture of air and 2-2,5% [v/v] Isoflurane, a vertical 62 
midline skin incision along the neck was made and the submaxillary glands were gently 63 
separated. The left common carotid artery was carefully isolated. Then the catheter 64 
was introduced into the carotid artery through a small incision in the vessel wall and 65 
the body of the transducer [PA-C10 model, Data Systems International (DSI), Overland 66 
Park, KS] was secured in a subcutaneous pouch along the animal’s right flank through 67 
the same ventral neck incision. The neck incision was closed with 3.0 silk. Mice were 68 
kept warm on a heating pad and monitored closely until full recovery from anesthesia 69 
and treated for 3 days by Metamizole (1.33 mg/ml in drinking water). Recording of 70 
blood pressure was continuously monitored a few days prior mating and during whole 71 
pregnancy by use of RLA 1020 telemetry receivers (DSI), BCM consolidation matrix 72 
(DSI), and an adapter, where the signal was demultiplexed. This output subsequently 73 
was band-pass filtered and amplified. The information was fed to data acquisition and 74 
recording system, Dataquest software (version 4.31 (DSI)). Acquired data was 75 
normalized to mean prior pregnancy for each value respectively (systolic and diastolic 76 
blood pressure, as well as mean arterial pressure) for the PE and Ctrl group. Here we 77 
did not analyze the Dox-Ctrl group since it has already been confirmed that Dox alone 78 
does not influence the blood pressure in a Dox-inducible transgenic rat model of type 79 
2 diabetes mellitus6. 80 
 81 
Tissue Preparation 82 
Tissue preparation was done as previously described1.At 14.5 (Ctrl n=6, Dox Ctrl n=4, 83 
PE n=6) or 18.5 dpc (Ctrl n=5, Dox Ctrl n=3, PE n=5), a distinct set of pregnant mice 84 
(compared to telemetry) were anesthetized via Ketamine 100 mg/kg body weight (BW) 85 
and Xylazine 10 mg/kg BW for an injection volume of 50µl/10g BW and killed by 86 
cervical dislocation or perfused with phosphate-buffered saline to obtain blood free 87 
organs (one dam per experimental group at 18.5 dpc). Maternal blood was collected; 88 
maternal kidneys and thoracic aortas, as well as whole implantation sites (14.5 dpc for 89 
histology) or fetuses, placentas and mesometrial triangle (MT) (14.5 dpc for mRNA; 90 
18.5 dpc for histology and mRNA) were dissected in sterile phosphate-buffered saline 91 
(PBS) and weighed with an ALJ 220-4NM analytical balance (Kern, Ebingen, 92 
Germany) with a linearity of ±0.2mg. Fetal and placental weight were measured after 93 
fetuses, placentas and MT were separated. Organs were either frozen and stored at 94 
−80°C (for RNA, DNA) or immediately fixed in 4% [w/v] paraformaldehyde (PFA) for 95 
24 h at 4°C and stored in 70% [v/v] ethanol at 4°C until being embedded in paraffin 96 
standard procedures (for morphology). 97 
 98 
Genomic DNA Isolation, Genotyping, and Sex Determination 99 
Genomic DNA was isolated from ear punch or fetal tail tissue samples as previously 100 
described1, 2, with the REDExtract-N-AmpTM Tissue PCR Kit (#XNAT; Sigma-Aldrich, 101 
St. Louis, MO, USA) according to the manufacturer’s protocol. Genotyping and sex 102 
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determination of mice were performed with a standard PCR program (hsFLT1: initial 103 
denaturation 95◦C, 5 min; 40 cycles 94°C, 45 s, 60◦C, 45 s, 72◦C, 1 min, final extension 104 
72°C,  5min; rtTA: initial denaturation 94°C, 3 min; 35 cycles 94°C, 45 s, 65°C, 1 min., 105 
72°C, 1 min, final extension 72°C, 2 min; Syr/IL-3: initial denaturation 95°C, 4 min 30s; 106 
35 cycles 95°C, 35 s, 50°C, 1 min, 72°C, 1 min, final extension 72°C, 5 min) and the 107 
appropriate primers (Table S1). 108 
 109 
Serum hsFLT1 measurements 110 
Serum samples were prepared as previously described1. Briefly, after centrifuging 111 
clotted blood for 15 min at 3000 g and 4°C; undiluted serum sample was used to 112 
measure the concentration of hsFLT1 with a BRAHMS KRYPTOR compact PLUS 113 
analyzer, according to the manufacturer’s protocol. The following dams were tested: 114 
At 14.5 dpc: Ctrl n = 6, Dox Ctrl n = 4 and PE n = 6, at 18.5 dpc Ctrl n = 11, Dox Ctrl n 115 
= 3 and PE n = 11. 116 
 117 
Serum Cytokine Array 118 
111 murine cytokines were simultaneously detected in serum of dams with a Proteome 119 
Profiler Mouse XL Cytokine Array according to the manufacturer's protocol (ARY028; 120 
R&D Systems, Minneapolis, MN USA). In principle, selected capture antibodies for 121 
each of 111 different angiogenesis proteins have been spotted in duplicate on 122 
nitrocellulose membranes. For cytokine detection, a total of 200 μl serum of a pooled 123 
sample of each condition (Ctrl n = 5, Dox Ctrl n = 5, PE low sFLT1 n = 5 and PE high 124 
sFLT1 n = 5; each 40 μl) was diluted and mixed with a cocktail of biotinylated detection 125 
antibodies. The sample/antibody mixture was incubated with the array membrane at 126 
4°C overnight. Streptavidin-horseradish peroxidase and chemiluminescent detection 127 
reagents were added, and chemiluminescence was detected with ChemiDoc™ XRS+ 128 
System (Bio-Rad Laboratories, Inc., Hercules, CA, USA). Pixel intensity for each spot 129 
was measured with Fiji/ImageJ3 and normalized to negative and reference spots. 130 
Normalized intensities of the pair of duplicate spots representing each cytokine were 131 
determined and the most relevant proteins were presented. 132 
 133 
Quantification of urinary albumin/creatinine ratio 134 
Random, single-void urine specimens gained on 18.5 dpc, were used to determine 135 
albumin-to-creatinine ratio for monitoring kidney function. Albumin concentration was 136 
determined by Mouse Albumin ELISA kit (ICL/Dunn Labortechnik, Asbach, Germany) 137 
according to manufacturer’s instructions. Creatinine levels were measured by 138 
colorimetric creatinine assay kit (Cayman chemical, Michigan, USA). The units for 139 
albumin/creatinine are mg/mg. The following dams were tested: 18.5 dpc: Ctrl, Dox-140 
Ctrl and PE n = 5. 141 
 142 
Histological analysis of kidneys 143 
For conventional light microscopy, paraffin sections (2 µm) were rehydrated via 144 
decreasing concentrations of ethanol and stained with two different staining methods: 145 
periodic acid Schiff (PAS) and acid fuchsin-orange G (AFOG). For PAS staining, 146 
tissues were immersed in 0.9% periodic acid (Carl Roth, Germany) for 10 min, followed 147 
by 10 min incubation with Schiff reagent (Merck Millipore, Germany) and 2 min 148 
incubation in Mayer’s hematoxylin solution (Sigma Aldrich, United States). For AFOG 149 
staining, sections were fixed via Bouin solution at 70°C for 1 h. Fixed tissues were 150 
submersed in Weigert’s hematoxylin (Carl Roth, Germany) for 5 minutes, followed by 151 
incubation in a solution of 4% HCl, 63% ethanol for 10 sec and incubation in 1% 152 
phosphomolybdic acid for 5 min. At last, the sections were incubated in AFOG solution 153 
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for 10 min. For both staining protocols after dehydration, kidney sections were covered 154 
with histomount using coverslips. Imaging was done via the Leica SCN400 Slide 155 
Scanner on a 40x magnification. 156 
 157 
Immunostaining of mouse kidney 158 
For immunostaining, the rehydrated paraffin-embedded kidney sections (3 µm) were 159 
demasked using Tris-EDTA pH=9.0 at 110°C for 10 minutes and blocked with 3% [w/v] 160 
fetal bovine serum for 5 minutes. Sections were incubated with the primary antibodies 161 
overnight at 4°C; anti-Cd31 polyclonal goat antibody (1:1000; R&D systems, 162 
Minneapolis, USA), anti-Nephrin polyclonal Guinea pig antibody (1:200; Fitzgerald, 163 
Acton, USA), and anti-WT1 monoclonal rabbit antibody (1:1000; Abcam, Berlin, 164 
Germany). Consequently, tissues were incubated with the corresponding secondary 165 
antibody. Afterwards, the coverslips were mounted with Prolong Gold antifade DAPI 166 
(Invitrogen, Carlsbad, CA). Images were obtained using confocal immunofluorescence 167 
microscopy; SP8 confocal microscope, Leica Microsystems in 63x magnification.  168 
 169 
Quantitative image analysis of mouse placenta and aorta 170 
For all placental analyses, formalin-fixed and paraffin-embedded samples were 171 
sectioned parallel to the mesometrial-fetal axis and aortas were sectioned at 5 µm and 172 
mounted on Superfrost Plus Slides (R. Langenbrinck, Emmendingen, Germany). 173 
Stained slides were scanned with the Aperio CS2 ScanScope slide scanner (Leica, 174 
Wetzlar, Germany) at 20× or 40× magnification (Westdeutsche Biobank, University 175 
Hospital Essen, Germany), and images were converted to TIFFs via Image Scope 176 
(Version 12.3.2.8013; Leica). Scanned slides were opened (plugin 177 
“bioformats_package.jar.”) and analyzed using Fiji/ImageJ3. Histological and 178 
immunohistochemical characterization of the spiral artery (SpA) remodeling was 179 
performed on two serial sections (Masson trichrome staining and PAS reaction), or on 180 
one serial section (for immunohistochemistry) at three different parts (100 µm interval) 181 
in the proximity of the umbilical cord, from each experimental group respectively (at 182 
14.5 and 18.5 dpc Ctrl n = 12, Dox Ctrl n = 10, PE wt n = 4, PE het n = 6 and PE hom 183 
n = 6; and at 18.5 dpc Ctrl n = 8, Dox Ctrl n = 6, PE wt n = 12, PE het n = 6 and PE 184 
hom n = 5). Histological characterization of maternal aortas was performed on two 185 
serial sections (Masson trichrome staining) at two different parts (100 µm interval) from 186 
each experimental group (at 18.5 dpc Ctrl n=5, Dox Ctrl n=3, PE n=5).  187 
 188 
Masson Goldner Trichrome staining of mouse placenta and aorta 189 
For morphometric analysis of SpA-remodeling and aorta histology, sections were 190 
stained with Masson-Goldner's trichrome (MGT) staining kit (#3459; Carl Roth GmbH, 191 
Karlsruhe, Germany) according to manufacturer’s protocol. In short, sections were 192 
deparaffinized, rehydrated, 3 min incubated with iron hematoxylin solution according 193 
to Weigert and 15 min blued in flowing tap water; followed by 5 min Goldner’s stain I, 194 
20 min Goldner’s stain II and 10 min Goldner’s stain III, plus rinsing with acetic acid 195 
solution 1% [v/v] in between and followed by a standard dehydration procedure and 196 
mounting in xylene mountant. MGT-staining visualizes nuclei in black, muscle cells in 197 
red/brown, erythrocytes in orange, and connective tissue in green. MGT-staining was 198 
used to quantify the lumen sizes of the mesometrial triangle and decidual arteries. The 199 
luminal and total vessel area was measured, and the luminal to total vessel area ratio 200 
was calculated as a marker for spiral arterial remodeling. A ratio of almost 1 represents 201 
a fully remodeled SpA, whereas a ratio below 1 represents worse SpA-remodeling. 202 




Verhoeff’s Van Gieson staining of mouse aorta 205 
For analysis of aortic elastin fibers, sections were stained with Verhoeff’s Van Gieson 206 
(VVG) stain kit (ab150667; Abcam, Cambridge, UK) according to manufacturer’s 207 
protocol. In short, sections were deparaffinized, rehydrated, 15 min incubated with 208 
working elastic stain solution (30 ml hematoxylin solution (5%), 12 ml ferric chloride 209 
solution (10%) and 12 ml Lugol’s iodine solution), followed by rinsing in tap water, short 210 
differentiation (Ferric Chloride (2%)) and 1 min incubation in sodium thiosulfate 211 
solution. Counterstain was performed by using Van Gieson’s solution for 3 min, 212 
followed by a standard dehydration procedure and mounting in xylene mountant. VVG-213 
staining visualizes nuclei in blue, elastic fibers in black, collagen in red and muscle 214 
cells in yellow. VVG-staining was used to analyze breaks, thinning and loss of elastic 215 
fibers of the thoracic aorta. 216 
 217 
Periodic Acid Schiff (PAS) reaction of mouse placenta 218 
Murine uterine natural killer (uNK) cells are recognized histochemically as containing 219 
glycoprotein-rich, cytoplasmic granules which react with Periodic Acid Schiff’s (PAS) 220 
reagent. For visualization of uNKs in the mouse placenta PAS reaction was used. 221 
Therefore, sections were deparaffinized, rehydrated, incubated 10 min with 1% 222 
periodic acid (#HP00.1; Carl Roth), washed in tap water, incubated 20 min with Schiff’s 223 
reagent (#X900.1; Carl Roth) and treated 3 x 2 min with sulfite water (18 ml 10% 224 
sodium-bisulfite solution + 300 ml distilled water + 15 ml 1M HCl) to reduce pseudo-225 
PAS reaction. Quantification of PAS-positive area of total decidua and MT 226 
compartment was performed without counterstain of the nuclei. 227 
 228 
Immunostaining of mouse placenta 229 
SpA-remodeling was specifically assessed by counting the percentage of cells with 230 
immunoreactivity on α-smooth muscle actin (α -SMA) and Pan-Cytokeratin (Cyto), as 231 
reported previously4. Lymphatic mimicry of endothelial cells was visualized by 232 
immunoreactivity on cluster of differentiation 31 (Cd31) and Fms-related tyrosine 233 
kinase 4 (Flt-4). Deparaffinized and rehydrated sections were used for 234 
immunostaining. Antigens were retrieved by boiling sections with citrate buffer (pH 7,0) 235 
for 20 min with 20 min cool-down following. Endogenous peroxidase was blocked 10 236 
min with H2O2 in methanol (1 ml methanol per 25 μl H2O2). After blocking 20 min with 237 
0,5% [w/v] bovine serum albumin (BSA) in PBS, sections were incubated separately 238 
overnight at 4°C with rabbit anti-α-SMA (1:500; RB-9010-80, Thermo-Scientific 239 
(Pittsburgh, USA)), rabbit anti-Cyto (1:500; Z0622, Dako, Glostruck, Denmark), rat 240 
anti-Cd31 (1:20; DIA310; Dianova, Hamburg, Germany), or rat anti-Flt4 (1:10; 552857, 241 
BD PharMingen, Carlifornia, USA) primary antibody. Bound primary antibody was 242 
visualized by 1 h incubation with goat anti-rabbit immunoglobulin G horseradish 243 
peroxidase secondary antibody (1:100; P0448, Dako) for α-SMA and Cyto at room 244 
temperature, followed by signal detection using the liquid DAB+ substrate chromogen 245 
system (#K3468; Dako, Carpinteria, CA, USA) or with rabbit anti-rat immunoglobulin 246 
G biotinylated (1:100; 31834, Thermo Scientific), followed by the vectastain elite ABC 247 
HRP Kit (PK-6100, Vector Laboratories, Burlingame, USA) according to 248 
manufacturer’s protocol and the liquid DAB+ substrate chromogen system. After 249 
washing, nuclei were counterstained 20 sec with hematoxylin followed by a standard 250 
dehydration procedure and mounting in xylene mountant. 251 
 252 
RNA Extraction, cDNA Synthesis, and Quantitative PCR of mouse placenta and 253 
mesometrial triangle tissue 254 
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Total RNA was extracted from ∼20mg of frozen tissue samples respectively with the 255 
RNeasy Mini Plus Kit (#74134, Qiagen, Hilden, Germany) according to the 256 
manufacturer’s protocol. The quality and quantity of DNA were verified with μCuvette 257 
G1.0 and BioPhotometer Plus (Eppendorf, Hamburg, Germany). Only RNA with 258 
260/280 = ~2.0 and 260/230 = 2.0-2.2 was used for complementary DNA (cDNA) 259 
synthesis. cDNA was synthesized with 2 μg RNA as previously described1, 2. Gene 260 
expression was measured from 1 μl cDNA with 19 μl of the PowerUP SYBR Green 261 
Master Mix (#A25742; Applied Biosystems, Foster City, CA, USA) and the ABI Prism 262 
7300 Sequence Detection System (Applied Biosystems) with a standard PCR 263 
program. The quantitative PCR (qPCR) analyses were carried out in triplicate. The 264 
amount of cDNA in each sample was normalized to glyceraldehyde-3-phosphate 265 
dehydrogenase (Gapdh) and β-Actin (Actb) as housekeeping genes and final gene 266 
expression analysis was done by standard curve method. Relative mRNA level was 267 
calculated by normalization to mean of the Ctrl group. Primer design was done with 268 
Primer3 and primer sequences are listed in Table S1. The following experimental 269 
groups were tested: At 14.5 dpc Ctrl n = 9, Dox Ctrl n = 9, PE wt n = 3 and PE het n = 270 
7, and at 18.5 dpc Ctrl n = 8, Dox Ctrl n = 6, PE wt n = 8 and PE het n = 6 for placental 271 
or MT tissue, respectively. 272 
 273 
Immunoblot analysis 274 
One half (∼20mg) of frozen MT tissue was homogenized in radioimmunoprecipitation 275 
assay (RIPA) protein extraction buffer as described previously5 [50 mM Tris/HCl, 150 276 
mM NaCl, 1% [w/v] NP-40, 0.25% [w/v] Na-deoxycholate, 1 mM 277 
ethylenediaminetetraacetic acid (EDTA)]. The protein content was determined with the 278 
Pierce BCA Protein Assay Kit (Thermo Scientific, Rockford, IL, USA). 20 µg of total 279 
protein lysates were separated on 4%–15% polyacrylamide gels (BioRad, USA). 280 
Following electrophoresis, proteins were transferred onto nitrocellulose membranes 281 
via semi-dry blotting for 1 h. Non-specific binding sites were blocked with 5% [w/v] milk 282 
powder solved in TBST (Tris-buffered saline with 0.1% [v/v] Tween20) for 1 h. 283 
Nitrocellulose membranes were incubated with antibodies specific for VEGFR-2/Flk-1 284 
(1:1000; #2479, Cell Signaling), VEGFR3/Flt-4 (1:200; AF743, R&D Systems), or β-285 
Actin Peroxidase (1:200.000; A3854, Sigma) in 0.5% [w/v] bovine serum albumin or 286 
0.5% [w/v] milk powder solved in TBS-T at 4°C overnight. Membranes were washed in 287 
TBST for three times and incubated for 1 h at room temperature with 1:5000 diluted 288 
anti-rabbit (p0448, DAKO), or donkey anti-goat HRP (sc2033, Santa Cruz 289 
Biotechnology) in 0.5% [w/v] milk powder in TBST. Detection was achieved with the 290 
SuperSignal West Dura Extended Duration Substrate Kit (Thermo Fisher Scientific) 291 
according to the protocol and detected using the Chemidoc XRS+ imaging system 292 
(BioRad, Feldkirchen, Germany). Protein level was determined by densitometric 293 
analyses of specific bands using Fiji/ImageJ3 and normalized against β-Actin. For 294 
normalization purposes, the same reference-sample ran on each blot as an internal 295 
control, together with the PageRuler™ Prestained Protein Ladder (Thermo Fisher 296 
Scientific, Pittsburgh, USA) to determine protein size. 297 
  298 
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Tables – Supplement 323 
 324 
Table S1: Oligonucleotide primer for quantitative real time PCR, genotyping and sex 325 
determination. 326 
Gene NCBI number Primer sequence (5′ → 3′) Product length (bp) 
Housekeeping genes 
β-Actin NM_007393.5 for: CCTCTATGCCAACACAGTGC 206 
  rev: CCTGCTTGCTGATCCACATC  
Gapdh XM_011241214.1 for: ACAACTCACTCAAGATTGTCAGCA 121 
  rev: ATGGCATGGACTGTGGTCAT  
Trophoblast invasion – Figure 3 
Plf NM_011954.3 for: AGGAGCCATGATTTTGGATG 203 
  rev: ACCAGGCAGGGTTCTTCTTT  
Mmp2 NM_008610.3 for: CGATGTCGCCCCTAAAACAG 176 
  rev: GCATGGTCTCGATGGTGTTC  
Mmp9 NM_013599.4 for: AAAACCTCCAACCTCACGGA 190 
  rev: GTGGTGTTCGAATGGCCTTT  
Tnfα NM_001278601.1 for: CGTCAGCCGATTTGCTATCT 206 
  rev: CGGACTCCGCAAAGTCTAAG  
Tgfβ NM_011577.2 for: TGCTTCAGCTCCACAGAGAA 182 
  rev: TGGTTGTAGAGGGCAAGGAC  
Infγ NM_008337.4 for: CGCTACACACTGCATCTTGG 181 
  rev: GTCACCATCCTTTTGCCAGT  
uterine natural killer (uNK) cell marker – Figure 4 
Cd56 NM_001311065.1 for: TTGTTCAAGCAGACACACCG 226 
  rev: TCAGGTTTCAGGCCCATGAT  
Cd49a NM_001033228.3 for: CCTTTCAAACTGAGCCCACC 170 
  rev: AATGTTGACGTCCCCATCCT  
Prf1 NM_011073.3 for: TCTTGGTGGGACTTCAGCTTTC 150 
  rev: TCTGCTTGCATTCTGACCGA  
Gzma NM_010370.3 for: CCTGAAGGAGGCTGTGAAAGAA 106 
  rev: CGCCAGCACAGATGGTATTTG  
Klrg1 NM_016970.1 for: AGGGAGTGAAGCTGTTTGGAG 77 
  rev: CCTCCAGCCATCAATGTTCCT  
Angiogenesis – Figure 5 
hsFLT1 XM_017020485.1 for: AATCATTCCGAAGCAAGGTG 221 
  rev: TTTCTTCCCACAGTCCCAAC  
Flk-1 NM_001363216.1 for: GGCGGTGGTGACAGTATCTT 162 
  rev: GTCACTGACAGAGGCGATGA  
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Flt-4 NM_008029.3 for: GTGGCTGTGAAGATGCTGAA 199 
  rev: TGACACGCAAGAAGTTGGAG  
Plgf XM_011244016.1 for: CGTCCTGTGTCCTTCTGAGT 200 
  rev: CCTCTTCCTCTTCCCCTTGG  
Vegfa NM_001025257.3 for: CAGGCTGCTGTAACGATGAA 140 
  rev: GCATTCACATCTGCTGTGCT  
Vegfb NM_011697.3 for: AACACAGCCAATGTGAATGC 157 
  rev: GGAGTGGGATGGATGATGTC  
Vegfc NM_009506.2 for: CAAGGCTTTTGAAGGCAAAG 159 
  rev: TCCCCTGTCCTGGTATTGAG  
Vegfd NM_001308489.1 for: CAACAGATCCGAGCAGCTTC 155 
  rev: AAAGTTGCCGCAAATCTGGT  
Hypoxia – Figure S3 
Hif1α NM_001313920.1 for: TCAAGTCAGCAACGTGGAAG 198 
  rev: TATCGAGGCTGTGTCGACTG  
Hif2α NM_010137.3 for: GCAAGCCTTCCAAGACACAA 228 
  rev: CCTGAGCTCCTGGTAGATGG  
Phd1 NM_001357767.1 for: TGCATCAAGTGGAGGAGGAG 246 
  rev: GATGCTCCTGGACGGTGATA  
Phd2 NM_001363475.1 for: AGGTGAGAAAGGTGTGAGGC 228 
  rev: CACAGTACAGTCCAGCAGA  
Genotyping 
hsFLT1 NM_001159920.2 for: CAAGGACGTAACTGAAGAGG 465 
  rev: TTTCTTCCCACAGTCCCAAC  
Col1a1  for: CCATCCCAACAATACATCACA 200 
  rev: TGGTTTCTTTGGGCTAGAGG  
rtTA  for: AAAGTCGCTCTGAGTTGTTAT  
  rev-wt: GGAGCGGGAGAAATGGATATG 650 
  rev-mut: GCGAAGAGTTTGTCCTCAACC 340 
Sex determination 
IL-3 NM_010556.4 for: GGGACTCCAAGCTTCAATCA 544 
  rev: TGGAGGAGGAAGAAAAGCAA  
Sry NM_011564.1 for: TGGGACTGGTGACAATTGTC 402 
  rev: GAGTACAGGTGTGCAGCTCT  
 327 
  328 
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Figures – Supplement 329 
 330 
Figure S1 331 
 332 
Figure S1: Maternal characteristics during experimental sFLT1-related 333 
preeclampsia. 334 
[A] Food and [B] doxycycline intake per day and [C] weight gain of dams during (Ctrl, 335 
Dox Ctrl and PE), showed no differences between experimental groups. [D] Systolic 336 
and [E] diastolic blood pressure during whole pregnancy of dams of Ctrl and PE group 337 
indicating hypertension exclusively upon hsFLT1 overexpression. [F] Thoracic aortas 338 
of dams at 18.5 dpc exhibited reduced aortic lumen, [G] combined with increase in 339 
aortic tunica media area and [H] decrease in elastin layers upon hsFLT1 expression 340 
(PE) compared to controls. [I] Mouse XL Cytokine Arrays incubated with 200 µl of 341 
pooled serum samples (n=5 dams) for each experimental group. [J] Most prominently 342 
changed cytokines are listed, showing downregulation of Adiponectin and upregulation 343 
of FGF acid and Myeloperoxidase upon hsFLT1 overexpression compared to controls 344 
(Ctrl and Dox Ctrl), depending on maternal hsFLT1 serum level. Data are presented 345 
as box plot with median, interquartile range ± upper/lower extreme, or as mean ± 346 
11 
 
standard error of the mean; sample size n is listed under each graph respectively; 347 
Kruskal-Wallis combined with Dunn's multiple comparisons test, or with Mann Whitney 348 
U test was used to set *p<0.05; **p<0.01; ***p<0.001 and ****p<0.0001. 349 
 350 




Figure S2: Immunofluorescence staining of glomeruli. [A] Double staining of 353 
glomeruli with slit diaphragm marker Nephrin (a, d, g) and endothelial cell marker Cd31 354 
(b, e, h). Compared to control mice (Ctrl, Dox Ctrl), systemically hsFLT1 expressing 355 
mice (PE) showed reduced Nephrin (g) and Cd31 staining (h). [B] Double staining of 356 
glomeruli with Nephrin antibody (a, d, g) and for podocyte specific transcription factor 357 
WT-1 (b, e, h) showing reduced Nephrin and WT-1 staining upon hsFLT1 expression 358 
(PE) compared to both controls (Ctrl and Dox Ctrl). Scale bar: 200µm. 359 
 360 
Figure S3 361 
 362 
Figure S3: Placental hsFLT1 mRNA expression, placental weight, placental 363 
efficiency (placental weight/fetal weight) and litter size. [A] hsFLT1 level of 364 
placental and MT tissue at 14.5 and [B] 18.5 dpc. [C] Placental weight, [D] placental 365 
efficiency (placental/fetal weight) and [E] litter size in the PE, Ctrl and Dox-Ctrl group 366 
at 14,5 and 18.5 dpc. The placental weight and the litter size did not change 367 
significantly among groups at both timepoints, but to a reduced placental efficiency 368 
upon hsFLT1 overexpression. Data are presented as box plot with median, 369 
interquartile range ± upper/lower extreme, or as mean ± standard error of the mean; 370 
sample size n is listed under each graph respectively; Kruskal-Wallis combined with 371 





Figure S4 375 
 376 
Figure S4: Mesometrial triangle markers. [A] Example image of the location of spiral 377 
arteries (SpA) in the two maternal implantation compartments decidua and 378 
mesometrial triangle (MT), scale bar: 1000 µm. [B] Example images of remodeled and 379 
unremodeled SpAs in the MT stained with Masson Goldner trichrome and illustration 380 
of luminal (pink line) to total vessel (orange line) area ratio calculation, scale bar: 100 381 
µm. [C] Representative images of the same decidual spiral artery (SpA) at 18.5 dpc of 382 
the PE group in different staining indicating many Cd31-, Flt-4 and Cytokeratin-positive 383 
cells and only a few αSMA-positive cells in the PAS-positive fibrinoid deposition 384 
surrounding the SpA. [D/E] mRNA expression analysis of Hypoxia-inducible factor 385 
(Hif1α, Hif2α) and Prolyl hydroxylases (Phd1, Phd2) at 14.5 dpc and at 18.5 dpc in 386 
placental tissue. [D] mRNA level of Hif1α and Hif2α were unaffected at 14.5 dpc but 387 
[E] upregulated upon maternal hsFLT1 overexpression (PE wt) at 18.5 dpc, whereas 388 
mRNA level of Phd1 and Phd2 were downregulated upon maternal hsFLT1 389 
overexpression (PE wt) at 14.5 dpc [F] and upregulated at 18.5 dpc [G]. Data are 390 
presented as box plot with median, interquartile range ± upper/lower extreme, or as 391 
mean ± standard error of the mean; sample size n is listed under each graph 392 
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respectively; Kruskal-Wallis combined with Dunn's multiple comparisons test, or with 393 
Mann Whitney U test was used to set *p<0.05; **p<0.01; ***p<0.001 and ****p<0.0001. 394 
